All three confirmed U.S. cases — one in
There, several kinds of bacteria are spreading that
carry a gene called NDM-1, which makes a carbapenem-destroying enzyme.
Carbapenems are key antibiotic weapons against these “Gram-negative”
bacteria, which are already challenging to treat.
Infectious disease experts have described the
situation as a potential nightmare scenario in which other bacteria
acquire the gene, rendering an entire class of antibiotics useless
against them.
The
The three U.S. cases involved three different
bacteria that remain susceptible to the antibiotics colistin, polymixin
and tigecycline, said
But “one of the problems is that use of these
antibiotics can also eventually result in resistance,” said Bush, who
spoke about resistant bacteria Monday at the
There are no drugs in Phase 3 clinical trials that
work against the NDM-1 mechanism, said Bush. But, she said, there are
some promising compounds in earlier stages of development.
Medical epidemiologist Dr.
he said, other bacteria already found in the state also can evade
carbapenems.
“That is not to downplay this,” he said. “It is
important, but this particular mechanism is just one of many that can
cause this kind of pattern.”
———
(c) 2010, Chicago Tribune.
Visit the
Distributed by McClatchy-Tribune Information Services.